Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring rpoB mutation H445Y is associated with suppressed immunity through type I interferons

Authors

Suhas Bobba, Washington University School of Medicine in St. Louis
Nicole C Howard, Washington University School of Medicine in St. Louis
Shibali Das, Washington University School of Medicine in St. Louis
Mushtaq Ahmed, Washington University School of Medicine in St. Louis
Linrui Tang, Columbia University
Shyamala Thirunavukkarasu, Washington University School of Medicine in St. Louis
Michelle H Larsen, Albert Einstein College of Medicine
Barun Mathema, Columbia University
Maziar Divangahi, McGill University
Shabaana A Khader, Washington University School of Medicine in St. Louis

Journal

mBio

Publication Date

10-31-2023

Volume

14

Issue

5

First Page

e0094623

Document Type

Open Access Publication

DOI

10.1128/mbio.00946-23

Rights and Permissions

Bobba S, Howard NC, Das S, Ahmed M, Tang L, Thirunavukkarasu S, Larsen MH, Mathema B, Divangahi M, Khader SA. Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring rpoB mutation H445Y is associated with suppressed immunity through type I interferons. mBio. 2023 Oct 31;14(5):e0094623. doi: 10.1128/mbio.00946-23. Epub 2023 Sep 8. © 2023 Bobba et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

Recommended Citation

Bobba, Suhas; Howard, Nicole C; Das, Shibali; Ahmed, Mushtaq; Tang, Linrui; Thirunavukkarasu, Shyamala; Larsen, Michelle H; Mathema, Barun; Divangahi, Maziar; and Khader, Shabaana A, "Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring rpoB mutation H445Y is associated with suppressed immunity through type I interferons." mBio. 14, 5. e0094623 (2023).
https://digitalcommons.wustl.edu/oa_4/2861

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.